Real Dollars for Real Patients: Prescription Intelligence at Scale

$55.1 million.

That’s how much Real-Time Prescription Benefit saved patients collectively in 2025, which shows what’s possible when benefit intelligence and prior authorization automation operate at national scale.

Is healthcare affordable? It’s a rhetorical question.

Affordability is a systemic issue, and this 2026 Gallup report makes that vividly clear: “[T]ens of millions of people forgo needed care or prescription medications because of cost, a trend that continues to this day.” One in three Americans feel forced to dial back on daily essentials (like utilities) to afford healthcare, and when you’re forced to dial back like this, promises of a better tomorrow won’t make you feel better about today.

So, with the trend continuing as it is, what to do about it?

We could start by saying that it’s not all doom and gloom. There is a reason for some optimism. There is proof that healthcare can be made more affordable—that it’s being made more affordable right now: Scaling up solutions for prescription intelligence results in millions of dollars in patient savings.

In fact, patients have already saved more than $19.5 million on their prescriptions so far in 2026 (January through April), on pace to exceed last year’s savings.

From Network Scale to Real-World Impact

Our Prescription Intelligence Impact Report shows that when prescription benefit intelligence and prior authorization automation are delivered directly into clinical workflows, patients experience fewer delays, lower out‑of‑pocket costs, and a clearer path to starting and staying on therapy.

Prescription intelligence when and where it’s needed delivers results in savings, speed and scale:

• Savings: In 2025, prescribers using Real-Time Prescription Benefit saved patients $55.1 million collectively—$77 on average per prescription and $817 on average per specialty prescription. That’s a utility bill. A car payment. A fridge full of food.
• Speed: Prior Authorization Automation flipped the determination and approval process from slow and manual to fast and automated, cutting median approval time to 18 seconds. 68,000 prescribers—an increase of 50% since December 2025—were enabled to improve medication access, reducing prescription abandonment (with another 119,000 prescribers expected to go live in 2026).
• Scale: A rule proposed by the Centers for Medicare & Medicaid Services (CMS) would boost savings and speed for more patients. CMS-0062-P clearly has the benefits of scale in mind, requiring electronic prior authorization and real-time prescription benefit capabilities to be put in place nationwide by October 2027.

The infrastructure for this new CMS rule is already here.

Real-Time Prescription Benefit and Prior Authorization Automation are two examples of that infrastructure. If passed, the rule would amplify the value of tools like these and expand interoperability across healthcare for payers, providers and healthcare clearinghouses.

The Scale Behind the Savings: 1 Billion Benefit Responses in 2025

More prescribers are using these tools. In turn, this leads to measurable results in both savings and speed to therapy: Prescribers used Real-Time Prescription Benefit a billion times in 2025. In the process, these prescribers are turning policy and technology into a tangible difference for patients.

Prescription intelligence when and where it’s needed removes friction, helps patients start therapy faster, and curbs medication costs.

It’s real dollars for real patients—a reason for some optimism in healthcare.